RenaissanceRe Hldgs saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 70 to 74.
IBD's proprietary rating tracks price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating as they launch their largest climbs. See if RenaissanceRe Hldgs can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
RenaissanceRe Hldgs is now considered extended and out of buy range after clearing a 239.42 buy point in a first-stage flat base. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Earnings growth declined in the most recent report from 40% to 22%. But revenue moved higher, from 53% to 116%.
The company earns the No. 5 rank among its peers in the Insurance-Property/Casualty/Title industry group. Kinsale Capital Group is the top-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
